» Articles » PMID: 38576913

The Role of Hydrogels in the Management of Brain Tumours: a Narrative Review

Abstract

Conventional therapeutic techniques for brain tumours have limitations and side effects, necessitating the need for alternative treatment options. MRI-monitored therapeutic hydrogel systems show potential as a non-surgical approach for brain tumour treatment. Hydrogels have unique physical and chemical properties that make them promising for brain tumour treatment, including the ability to encapsulate therapeutic agents, provide sustained and controlled drug release, and overcome the blood-brain barrier for better penetration. By combining hydrogel systems with MRI techniques, it is possible to develop therapeutic approaches that provide real-time monitoring and controlled release of therapeutic agents. Surgical resection remains important, but there is a growing need for alternative approaches that can complement or replace traditional methods. The objective of this comprehensive narrative review is to evaluate the potential of MRI-monitored therapeutic hydrogel systems in non-surgical brain tumour treatment.

References
1.
Chen C, Jing W, Chen Y, Wang G, Abdalla M, Gao L . Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. Sci Transl Med. 2022; 14(656):eabn1128. DOI: 10.1126/scitranslmed.abn1128. View

2.
Tsui C, Koss K, Churchward M, Todd K . Biomaterials and glia: Progress on designs to modulate neuroinflammation. Acta Biomater. 2018; 83:13-28. DOI: 10.1016/j.actbio.2018.11.008. View

3.
Burkett C, Patel S, Tabor M, Padhya T, Vale F . Polyethylene glycol (PEG) hydrogel dural sealant and collagen dural graft matrix in transsphenoidal pituitary surgery for prevention of postoperative cerebrospinal fluid leaks. J Clin Neurosci. 2011; 18(11):1513-7. DOI: 10.1016/j.jocn.2011.04.005. View

4.
Jogalekar M, Cooper L, Serrano E . Hydrogel Environment Supports Cell Culture Expansion of a Grade IV Astrocytoma. Neurochem Res. 2017; 42(9):2610-2624. PMC: 6217807. DOI: 10.1007/s11064-017-2308-7. View

5.
Dzhonova D, Olariu R, Leckenby J, Dhayani A, Vemula P, Prost J . Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging. PLoS One. 2018; 13(8):e0203409. PMC: 6117083. DOI: 10.1371/journal.pone.0203409. View